TE_197

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MIR
TE superfamily L2-end
TE class SINE
Gene CAPZB
Class Chimeric
Coding Non-coding, Other
Tumor-specific score 3.87
Counts of samples TCGA_tumor:1218; TCGA_normal:17; GTEx:337
TSS chr1(-):19436034



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_197.1 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19344358,19344434,19345187,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.2 CAPZB Chimeric Other MRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLYFEGGVSSVYLWDLDHGFAGVILIKKAGDGSKKIKGCWDSIHVVEVQEKSSGRTAHYKLTSTVMLWLQTNKSGSGTMNLGGSLTRQMEKDETVSDCSPHIANIGRLVEDMENKIRSTLNEIYFGKTKDIVNGLRSIDAIPDNQKFKQLQRELSQVLTQRQIYIQPDN* chr1(-):19339597,19339617,19342752,19342864,19344358,19344434,19345187,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.3 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19345187,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.4 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19344358,19344434,19345187,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19412236,19417164,19419661,19419750,19435895,19436035
teRNA_197.5 CAPZB Chimeric Other MRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLYFEGGVSSVYLWDLDHGFAGVILIKKAGDGSKKIKGCWDSIHVVEVQEKSSGRTAHYKLTSTVMLWLQTNKSGSGTMNLGGSLTRQMEKDETVSDCSPHIANIGRLVEVSDLGSGWLLQ* chr1(-):19339597,19339617,19344358,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.6 CAPZB Chimeric Other MRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLYFEGGVSSVYLWDLDHGFAGVILIKKAGDGSKKIKGCWDSIHVVEVQEKSSGRTAHYKLTSTVMLWLQTNKSGSGTMNLGGSLTRQMEKDETVSDCSPHIANIGRLVEVSDLGSGWLLQ* chr1(-):19339597,19339617,19342752,19342864,19344358,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.7 CAPZB Chimeric Non-coding Non-coding chr1(-):19344414,19344434,19345187,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.8 CAPZB Chimeric Non-coding Non-coding chr1(-):19342844,19342864,19344358,19344434,19345187,19345252,19356635,19356751,19357422,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035
teRNA_197.9 CAPZB Chimeric Non-coding Non-coding chr1(-):19357543,19357563,19378540,19378653,19385505,19385626,19419661,19419750,19435895,19436035


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).